The pharmaceutical industry is entering an era of mega-blockbusters, drugs with annual sales of $10 billion or more, that ...

In abdominoplasty, cebranopadol increased the proportion of patients requiring no opioid rescue medication versus placebo, ...

A $50,000-per-dose threshold for clinician-administered drugs can standardize high-cost identification, while allowing ...

Michael Chancley Jr.’s personal experience with PrEP informs his work at PrEP4All as he advocates for expanded access and ...

The "direct-to" channel was a hot topic at the Asembia specialty pharmacy meeting this week in Las Vegas. The drug supply ...

The ACA individual exchange exit is positioned as a strategic de-emphasis of a shrinking line, with no 2026 network changes ...

A high-touch specialty pharmacy program that combines pharmacist support, telehealth and value-based care reduced medical ...

A pharmacist-led specialty pharmacy model that expands into care management services could help health systems improve ...

National Priority Vouchers aim to shorten FDA review from ~10–12 months to ~1–2 months using collaborative multidisciplinary ...

Health system specialty pharmacy programs are expanding beyond traditional roles to support value-based care, according to a ...

Cell and gene therapies are currently niche products, even within specialty pharmacy, drugs that, by most definitions, are ...

Whole-mount immunolabeling enabled high-resolution visualization of peripheral nerve infiltration patterns within melanoma, ...